Cited by CrossRef (22)

  1. Mitsuyoshi Yamagata, Mutsumi Tsuchishima, Takashi Saito, Mikihiro Tsutsumi, Joseph George. Therapeutic implication of human placental extract to prevent liver cirrhosis in rats with metabolic dysfunction-associated steatohepatitis. 2024;138:327
    https://doi.org/10.1042/CS20230533
  2. Almir Fajkić, Rijad Jahić, Almira Hadžović-Džuvo, Orhan Lepara. Adipocytokines as Predictors of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Development in Type 2 Diabetes Mellitus Patients. 2024
    https://doi.org/10.7759/cureus.55673
  3. T.M. Bentsa. Nonalcoholic fatty liver disease associated with obesity and type 2 diabetes and gut dysbiosis. Mìžnarodnij endokrinologìčnij žurnal 2024;20:120
    https://doi.org/10.22141/2224-0721.20.2.2024.1373
  4. Divya Choudhary, Gabriella A. Andreani, Saleh Mahmood, Xiaozhong Wen, Mulchand S. Patel, Todd C. Rideout. Postnatal Consumption of Black Bean Powder Protects against Obesity and Dyslipidemia in Male Adult Rat Offspring from Obese Pregnancies. Nutrients 2024;16:1029
    https://doi.org/10.3390/nu16071029
  5. Alina M. Allen, Michael Charlton, Kenneth Cusi, Stephen A. Harrison, Kris V. Kowdley, Mazen Noureddin, Jay H. Shubrook. Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate Medicine 2024
    https://doi.org/10.1080/00325481.2024.2325332
  6. Akiko Sakurai, Toshihiro Sakurai, Hsin-Jung Ho, Hitoshi Chiba, Shu-Ping Hui. Kaempferol Improves Cardiolipin and ATP in Hepatic Cells: A Cellular Model Perspective in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients 2024;16:508
    https://doi.org/10.3390/nu16040508
  7. Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Masashi Shimoda, Yuka Nogami, Yoshiko Shirakiya, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto. Dipeptidyl peptidase‐4 inhibitor and sodium‐glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high‐fat diet‐fed mice. Diabetes Obesity Metabolism 2024
    https://doi.org/10.1111/dom.15548
  8. Kathryn J. Fowler, Victoria Chernyak. What Is in a Name: Understanding the Nomenclature Updates for Fatty Liver Disease. Radiology 2024;310
    https://doi.org/10.1148/radiol.232771
  9. Agata Tomaszewska, Weronika Gonciarz, Tomasz Rechcinski, Magdalena Chmiela, Anna K. Kurdowska, Agnieszka Krupa. Helicobacter pylori components increase the severity of metabolic syndrome and its hepatic manifestations induced by a high fat diet. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-024-56308-7
  10. Harold Edward Bays, Carol Kirkpatrick, Kevin C. Maki, Peter P. Toth, Ryan T. Morgan, Justin Tondt, Sandra Michelle Christensen, Dave Dixon, Terry A. Jacobson. Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the obesity medicine association and the National Lipid Association 2024. Obesity Pillars 2024:100108
    https://doi.org/10.1016/j.obpill.2024.100108
  11. Anna Di Sessa, Stefano Guarino, Giuseppina Rosaria Umano, Emanuele Miraglia del Giudice, Pierluigi Marzuillo. MASLD vs. NAFLD: A better definition for children with obesity at higher risk of kidney damage. Journal of Hepatology 2024;80:e87
    https://doi.org/10.1016/j.jhep.2023.10.021
  12. Nan Zhu, Yongfeng Song, Chen Zhang, Kai Wang, Junming Han. Association between the peripheral neutrophil-to-lymphocyte ratio and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes. Front. Med. 2023;10
    https://doi.org/10.3389/fmed.2023.1294425
  13. Milena Vesković, Nikola Šutulović, Dragan Hrnčić, Olivera Stanojlović, Djuro Macut, Dušan Mladenović. The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach. CIMB 2023;45:9084
    https://doi.org/10.3390/cimb45110570
  14. Yong Chen, Chen Xie, Yining Lei, Dan Ye, Le Wang, Fang Xiong, Hui Wu, Qiang He, Hongfu Zhou, Ling Li, Jun Xing, Cai Wang, Min Zheng. Theabrownin from Qingzhuan tea prevents high-fat diet-induced MASLD via regulating intestinal microbiota. Biomedicine & Pharmacotherapy 2024;174:116582
    https://doi.org/10.1016/j.biopha.2024.116582
  15. Charalambos Fotakis, Athina I. Amanatidou, Maria Kafyra, Vasiliki Andreou, Ioanna Panagiota Kalafati, Maria Zervou, George V. Dedoussis. Circulatory Metabolite Ratios as Indicators of Lifestyle Risk Factors Based on a Greek NAFLD Case–Control Study. Nutrients 2024;16:1235
    https://doi.org/10.3390/nu16081235
  16. Yumin Wang, Joshua S. Fleishman, Tongda Li, Yulin Li, Zhao Ren, Jichao Chen, Mingchao Ding. Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma. Front. Pharmacol. 2024;14
    https://doi.org/10.3389/fphar.2023.1336216
  17. Pablo Martínez-Blanco, Miguel Suárez, Sergio Gil-Rojas, Ana María Torres, Natalia Martínez-García, Pilar Blasco, Miguel Torralba, Jorge Mateo. Prognostic Factors for Mortality in Hepatocellular Carcinoma at Diagnosis: Development of a Predictive Model Using Artificial Intelligence. Diagnostics 2024;14:406
    https://doi.org/10.3390/diagnostics14040406
  18. Ting Wang, Dehua Wang, Ge Kuang, Xia Gong, Li Zhang, Jingyuan Wan, Ke Li. Derlin-1 promotes diet-induced non-alcoholic fatty liver disease via increasing RIPK3-mediated necroptosis. Free Radical Biology and Medicine 2024;217:29
    https://doi.org/10.1016/j.freeradbiomed.2024.03.014
  19. Aditya Viswanath, Sherouk Fouda, Cornelius James Fernandez, Joseph M Pappachan. Metabolic-associated fatty liver disease and sarcopenia: A double whammy. World J Hepatol 2024;16:152
    https://doi.org/10.4254/wjh.v16.i2.152
  20. Muhammed Mubarak. Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities. World J Gastrointest Pathophysiol 2024;15
    https://doi.org/10.4291/wjgp.v15.i1.92864
  21. Adriana Campos-Espinosa, Carolina Guzmán, Karla Zaira Medina-Ávila, Gabriela Gutierrez-Reyes. In Vitro Lipid Overload Affects Cellular Proliferation, Apoptosis, and Senescence in a Time-Dependent Manner in HepG2 Hepatocytes and LX-2 Hepatic Stellate Cells. Cells 2024;13:282
    https://doi.org/10.3390/cells13030282
  22. Paulina Vidal-Cevallos, Adriana P. Sorroza-Martínez, Norberto C. Chávez-Tapia, Misael Uribe, Eduardo E. Montalvo-Javé, Natalia Nuño-Lámbarri. The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum. IJMS 2024;25:4397
    https://doi.org/10.3390/ijms25084397